Pilot randomised study of early intervention based on tumour markers in the follow-up of patients with primary breast cancer
Open Access
- 1 October 2014
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 23 (5) , 567-572
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancersBreast Cancer Research and Treatment, 2013
- Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysisJournal of Comparative Effectiveness Research, 2013
- Diagnostic Role of Tumour Markers CEA, CA15-3, CA19-9 and CA125 in Lung CancerIndian Journal of Clinical Biochemistry, 2012
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trialThe Lancet, 2010
- Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?Clinical Chemistry, 2006
- T1-weighted magnetic resonance imaging in breast cancer vertebral metastases: Changes on treatment and correlation with response to therapyClinical Radiology, 1998
- Prolonged survival by 'early' salvage treatment of breast cancer patients: a retrospective 6-year studyBritish Journal of Cancer, 1997
- Prospective confirmation of a biochemical index for measuring therapeutic efficacy in metastatic breast cancer in a multicentre studyThe Breast, 1996
- Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?British Journal of Cancer, 1993
- Objective measurement of therapeutic response in breast cancer using tumour markersBritish Journal of Cancer, 1991